Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive randomized double-blind phase 2/3 trial of clofoctol (TEE001DP) in early symptomatic COVID-19
2021-000045-41Phase 2Completed
- Sponsor
- Institut Pasteur
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Clofoctol (TEE001DP) with Placebo (2 arms). Started Apr 2021; status: completed.
02
Drugs
clofoctol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-000045-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000045-41.